1887

Abstract

The differential influence of individual amino acids on the growth of versus () was investigated. Certain essential amino acids added in excess at the middle of the infection course resulted in varying degrees of abnormality in the development of the two species. If amino acids were added as early as 2 h post-infection, these effects were even more pronounced. The most effective amino acids in terms of growth inhibition were leucine, isoleucine, methionine and phenylalanine. These amino acids elicited similar effects against , except methionine, which, surprisingly, showed a lower inhibitory activity. Tryptophan and valine marginally inhibited growth and, paradoxically, led to a considerable enhancement of growth. On the other hand, some non-essential amino acids administered at the middle of or throughout the infection course differentially affected the development of the two species. For example, growth was efficiently inhibited by glycine and serine, whereas was relatively less sensitive to these agents. Another difference was apparent for glutamate, glutamine and aspartate, which stimulated growth more than that of . Overall, several distinctive patterns of susceptibility to excess amino acid levels were revealed for two representative and isolates. Perturbation of amino acid levels, e.g. of leucine and isoleucine, might form a basis for the development of novel treatment or preventive regimens for chlamydial diseases.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46445-0
2006-07-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/7/879.html?itemId=/content/journal/jmm/10.1099/jmm.0.46445-0&mimeType=html&fmt=ahah

References

  1. Allan I., Pearce J. H. 1983; Differential amino acid utilization by Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) and its regulatory effect on chlamydial growth. J Gen Microbiol 129:1991–2000
    [Google Scholar]
  2. Allan I., Hatch T. P., Pearce J. H. 1985; Influence of cysteine deprivation on chlamydial differentiation from reproductive to infective life-cycle forms. J Gen Microbiol 131:3171–3177
    [Google Scholar]
  3. Al-Younes H. M., Rudel T., Meyer T. F. 1999; Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol 1:237–247 [CrossRef]
    [Google Scholar]
  4. Al-Younes H. M., Rudel T., Brinkmann V., Szczepek A. J., Meyer T. F. 2001; Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol 3:427–437 [CrossRef]
    [Google Scholar]
  5. Al-Younes H. M., Brinkmann V., Meyer T. F. 2004; Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway. Infect Immun 72:4751–4762 [CrossRef]
    [Google Scholar]
  6. Byrne G. I., Kalayoglu M. V. 1999; Chlamydia pneumoniae and atherosclerosis: links to the disease process. Am Heart J 138:S488–S490 [CrossRef]
    [Google Scholar]
  7. Coles A. M., Pearce J. H. 1987; Regulation of Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) growth in McCoy cells by amino acid antagonism. J Gen Microbiol 133:701–708
    [Google Scholar]
  8. Coles A. M., Reynolds D. J., Harper A., Devitt A., Pearce J. H. 1993; Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis?. FEMS Microbiol Lett 106:193–200 [CrossRef]
    [Google Scholar]
  9. Grieshaber S., Swanson J. A., Hackstadt T. 2002; Determination of the physical environment within the Chlamydia trachomatis inclusion using ion-selective ratiometric probes. Cell Microbiol 4:273–283 [CrossRef]
    [Google Scholar]
  10. Harper A., Pogson C. I., Jones M. L., Pearce J. H. 2000; Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect Immun 68:1457–1464 [CrossRef]
    [Google Scholar]
  11. Hatch T. P. 1975; Competition between Chlamydia psittaci and L cells for host isoleucine pools: a limiting factor in chlamydial multiplication. Infect Immun 12:211–220
    [Google Scholar]
  12. Iliffe-Lee E. R., McClarty G. 2000; Regulation of carbon metabolism in Chlamydia trachomatis . Mol Microbiol 38:20–30 [CrossRef]
    [Google Scholar]
  13. Kalman S., Mitchell W., Marathe R. & 7 other authors; 1999; Comparative genomes of Chlamydia pneumoniae and C. trachomatis . Nat Genet 21:385–389 [CrossRef]
    [Google Scholar]
  14. Karayiannis P., Hobson D. 1981; Amino acid requirements of a Chlamydia trachomatis genital strain in McCoy cell cultures. J Clin Microbiol 13:427–432
    [Google Scholar]
  15. Kuo C.-C., Grayston J. T. 1990; Amino acid requirements for growth of Chlamydia pneumoniae in cell cultures: growth enhancement by lysine or methionine depletion. J Clin Microbiol 28:1098–1100
    [Google Scholar]
  16. Kuo C.-C., Jackson L. A., Campbell L. A., Grayston J. T. 1995; Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451–461
    [Google Scholar]
  17. McClarty G. 1994; Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 2:157–164 [CrossRef]
    [Google Scholar]
  18. Nicholson T. L., Olinger L., Chong K., Schoolnik G., Stephens R. S. 2003; Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis . J Bacteriol 185:3179–3189 [CrossRef]
    [Google Scholar]
  19. Ojcius D. M., Degani H., Mispelter J., Dautry-Varsat A. 1998; Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia : NMR studies of living cells. J Biol Chem 273:7052–7058 [CrossRef]
    [Google Scholar]
  20. Peeling R. W., Brunham R. C. 1996; Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 2:307–319 [CrossRef]
    [Google Scholar]
  21. Schachter J. 1999; Infection and disease epidemiology. In Chlamydia : Intracellular Biology, Pathogenesis, and Immunity pp  139–169 Edited by Stephens R. S. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  22. Schaumburg C. S., Tan M. 2006; Arginine-dependent gene regulation via the ArgR repressor is species specific in Chlamydia . J Bacteriol 188:919–927 [CrossRef]
    [Google Scholar]
  23. Shaw A. C., Christiansen G., Roepstorff P., Birkelund S. 2000; Genetic differences in the Chlamydia trachomatis tryptophan synthase alpha-subunit can explain variations in serovar pathogenesis. Microbes Infect 2:581–592 [CrossRef]
    [Google Scholar]
  24. Stephens R. S., Kalman S., Lammel C. & 9 other authors; 1998; Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis . Science 282:754–759 [CrossRef]
    [Google Scholar]
  25. Thylefors B., Negrel A. D., Pararajasegaram R., Dadzie K. Y. 1995; Global data on blindness. Bull W H O 73:115–121
    [Google Scholar]
  26. Tipples G., McClarty G. 1993; The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates. Mol Microbiol 8:1105–1114 [CrossRef]
    [Google Scholar]
  27. Wolf K., Fischer E., Hackstadt T. 2000; Ultrastructural analysis of developmental events in Chlamydia pneumoniae -infected cells. Infect Immun 68:2379–2385 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46445-0
Loading
/content/journal/jmm/10.1099/jmm.0.46445-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error